The most talked about and most notable calls for studies on Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.
Top 5 Upgrades:
-
Wells Fargo Enhanced DraftKings (DKNG) to Overweight from Equal Weight with a price target of $49, up from $31, as part of a broader search forecasting 2026 in digital gaming. The company remains optimistic about the long-term growth momentum of the digital sector and forecasts robust earnings growth for 2026, although it also believes that DraftKings offers better near-term upside potential with expectations of a “strong” fourth quarter for the company.
-
Citi improved Intel (INTC) to Neutral from Sell with a price target of $50, up from $29, following a hedge transfer. The company believes that Intel benefits from the “tightness” of the supply of advanced packaging at TSMC (TSM).
-
JPMorgan updated F5 (FFIV) to overweight from neutral with a price target of $345, up from $295. The company believes the risks contemplated in the company’s outlook for fiscal 2026 due to the security incident are “too conservative.”
-
Wells Fargo Enhanced Broadcom (AVGO) overweight from Equal Weight with a price target of $430, up from $410. The company believes concerns about gross margin are overblown. Wells also upgraded Monolithic Power (MPWR), Lam Research (LRCX), KLA Corp. (KLAC) and Analog Devices (ADI) overweight for pound for pound.
-
Barclays improved Dell Technologies (DELL) overweight since Equal Weight with an unchanged price target of $148. The company is more positive on the stock given the strength Dell is seeing in AI server orders.
Top 5 downgrades:
-
Wells Fargo downgraded Flutter Entertainment (FLUT) to Equal Weight from Overweight with a price target of $228, up from $248, as part of a broader search forecasting 2026 in digital gaming. Flutter’s lower growth and higher promotion are offset by improved year-over-year net sustainment “missed returns,” Wells Fargo added.
-
UBS degraded GE Health (GEHC) to sell from neutral with a price target of $77, up from $73. The company says the “enthusiasm” around Flyrcado and photon counting CT is understandable, but it now sees risks as the company’s “best execution scenarios” are priced into the stock’s price.
-
Morgan Stanley downgraded Albertson (ACI) to Underweight from Equal Weight with a price target of $14, down from $20. The company cites the company’s loss of market share, pressure from pharmacies and disinflation to explain the downgrade.
-
KeyBanc decommissioned Rocket Lab (RKLB) to sector weighting from overweight without price target. The company’s multi-year growth catalysts “have become reality” and are now generally well known, the company tells investors in a research note.
-
Barclays downgraded Nutanix (NTNX) to Equal Weight from Overweight with a price target of $53, up from $64. Barclays expects a slowdown in stock acquisitions, which would hurt bookings and create longer deal cycles.
